-
RRP Restores Lipid Metabolism in Hepatic IRI
2026-09-19
A 2024 Journal of Ethnopharmacology study shows that Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury by correcting hepatocyte cholesterol handling, rather than acting only as a general hepatoprotective treatment. Its key mechanistic contribution is an AMPK–mTOR-centered pathway that suppresses SCAP–SREBP2 cholesterol synthesis while promoting LXRα-dependent cholesterol efflux.
-
Thiamet G: O-GlcNAcase Inhibitor Workflows
2026-09-19
Thiamet G provides a controlled way to raise protein O-GlcNAcylation in neuronal, leukemia, differentiation, and emerging placental stress assays. This guide connects concentration design, orthogonal readouts, tau and ferroptosis workflows, and troubleshooting to the HUWE1–TfR1 mechanism reported in preeclampsia research.
-
AG-120 (Ivosidenib) IDH1 Research Workflows
2026-09-18
AG-120 (Ivosidenib) enables a practical mutant-IDH1 workflow that connects 2-hydroxyglutarate reduction with differentiation phenotypes in AML models. This guide combines dosing, metabolite analysis, CD44-aware assay design, and troubleshooting for more interpretable results.
-
Triacetin Digestion and Hepatic Metabolic Signaling
2026-09-17
A 2025 rat study shows that triacetin is completely degraded in the upper gastrointestinal tract and absorbed mainly as acetate and glycerol rather than reaching the colon intact. The findings connect short-chain triacylglycerol digestion with hepatic AMPK activation, altered lipid-related gene expression, and a broader substrate-plus-signal model of nutrient metabolism.
-
BCLAF1–YTHDF2–SIX1 Axis in ESCC Progression
2026-09-17
The reference study identifies a BCLAF1–YTHDF2–SIX1 regulatory axis that connects m⁶A-dependent RNA turnover with glycolysis and malignant behavior in esophageal squamous cell carcinoma. Its integration of protein-interaction assays, MeRIP-seq, RIP-seq, transcriptomics, functional studies, and in vivo validation provides a mechanistic framework for interpreting BCLAF1 as a regulator of RNA fate rather than only a transcription-associated factor.
-
PMSF: Preserving Mechanistic Signal in Cardiac Ablation
2026-09-17
Phenylmethanesulfonyl fluoride (PMSF) is more than a routine lysis-buffer additive: it is a selective measurement-control reagent for translational studies in which proteolysis can blur mechanistic interpretation. This article connects PMSF-enabled protein preservation with recent findings on microsecond pulsed electric fields, mitochondrial injury, and cardiomyocyte death, while clearly separating established evidence from workflow recommendations and identifying the limits of serine protease inhibition.
-
Farnesylation-Driven KRAS Phase Separation in Colon Cancer
2026-09-16
The reference study identifies farnesylation-dependent liquid–liquid phase separation as a regulatory mechanism that concentrates KRAS and RCE1, improves KRAS processing, and promotes colon tumor growth. Its findings also suggest that disrupting this condensate state with pitavastatin can strengthen responses to KRAS G12C inhibition, although further validation is needed before clinical translation.
-
Everolimus (RAD001): From Signal to Response
2026-09-15
A translational framework for using Everolimus (RAD001) to connect mTOR target engagement with interpretable cancer phenotypes, realistic exposure design, and stronger preclinical decisions.
-
MK-5108 (VX-689) Aurora A Workflows
2026-09-15
Build selective Aurora A experiments across biochemical, cell-cycle, retinoblastoma, and xenograft models with MK-5108 (VX-689). This guide emphasizes assay design, dose interpretation, solubility control, and the distinction between AURKA expression and demonstrated tumor dependence.
-
Butylated Hydroxyanisole (BHA) Workflow Guide
2026-09-14
Build more interpretable oxidative stress experiments with Butylated hydroxyanisole (BHA) by separating stock preparation, redox perturbation, and endpoint analysis. The workflow combines ROS detection, viability controls, and orthogonal validation so antioxidant protection is not mistaken for nonspecific assay interference.
-
Sodium chloride B7288: Buffer Preparation and QC
2026-09-14
Sodium chloride B7288 is an inorganic salt used to adjust ionic strength and osmotic balance in aqueous buffers, biochemical assays, and cell culture media workflows. This guide covers calculation, dissolution, QC, storage, and boundaries such as its incompatibility with DMSO or ethanol as preparation solvents and its lack of sterility or pH-buffer qualification.
-
Pyridostigmine, α7 Signaling, and Placental Necroptosis
2026-09-13
The reference study identifies placental necroptosis as a modifiable feature of placental ischemia-driven preeclampsia-like pathology in rats. Pharmacological evidence using pyridostigmine, α-bungarotoxin, and necrostatin-1 connects enhanced non-neuronal cholinergic signaling with reduced necroptosis, inflammation, oxidative stress, and trophoblast dysfunction.
-
Anti-inflammatory Anti-angiogenic Airway Stent
2026-09-12
Zhao and colleagues developed an electrospun airway stent, PAGL, that combines anlotinib hydrochloride with silver nanoparticles to address the linked processes of infection, inflammation, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. In vitro, in vivo, and RNA-sequencing results indicate that this multifunctional design can reduce biological drivers of restenosis, although validation in longer-term and clinical models remains necessary.
-
HyperScribe All in One mRNA Synthesis Kit Plus 1
2026-09-12
The HyperScribe All in One mRNA Synthesis Kit Plus 1 combines co-transcriptional ARCA capping, 5mCTP and ψUTP incorporation, DNase treatment, and enzymatic poly(A) tailing in one workflow. It is especially useful for RNA vaccine development, modified-mRNA translation studies, and immune-response optimization where RNA quality and translational performance must be controlled together.
-
c-Myc tag Peptide: Assay Control & Mechanistic Insight
2026-09-11
The c-Myc Peptide is more than a competitive reagent: it provides a defined way to test epitope-dependent detection, distinguish abundance from activity, and improve immunoassay interpretation. This article connects c-Myc tag workflows with transcription-factor stability research while clearly separating validated applications from cross-domain hypotheses.